Fracture (FX) Improvement With Teriparatide: FiX-IT Study
Phase of Trial: Phase IV
Latest Information Update: 15 Dec 2017
Price : $35 *
At a glance
- Drugs Teriparatide (Primary)
- Indications Fracture; Postmenopausal osteoporosis
- Focus Biomarker; Therapeutic Use
- Acronyms FiX-IT
- 05 Oct 2016 Status changed from active, no longer recruiting to completed.
- 25 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2015 Planned End Date changed from 1 Nov 2016 to 1 Jun 2017, as reported by ClinicalTrials.gov.